Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education (EDUCATE)

September 2, 2026 updated by: University of California, Davis

Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education (EDUCATE)

The University of California Davis, Comprehensive Cancer Center's (UCDCCC) Office of Community Outreach and Engagement (OCOE) serves the 19 catchment counties which approximately consists of 5 million residents. Currently, the overall catchment population cancer screening rates fall below 80%. The aim of OCOE is to increase cancer education (prevention, screening, and vaccination) and training. Through education, and encouraging participation in routine screening for early detection, this can help increase cancer knowledge. In addition to cancer education, OCOE wants to educate community members regarding modifiable risk factors which include tobacco usage, being overweight/obese (physical inactivity/poor nutrition), and lack of immunizations. By increasing knowledge of cancer prevention, screening, and vaccination this will help community members become more aware of their cancer risk.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Objective: To determine the effects of health education, outreach, and training activities on cancer control and prevention knowledge, attitudes, beliefs, and behaviors among the University of California Davis, Comprehensive Cancer Center's (UCDCCC) catchment area residents. There are 3 Specific Aims for EDUCATE.

Specific Aim 1: To educate catchment area residents on modifiable risk factors for cancer (e.g., screening, behavior, vaccination) and the importance of participation in cancer research.

Specific Aim 2: Provide participants with educational materials on cancer prevention, screening, and vaccination.

Specific Aim 3: Evaluate the effectiveness of the health education, outreach, and training through the analyses of quantitative and qualitative data collected from the health education activities.

Study Type

Observational

Enrollment (Estimated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • United States
    • California
      • Sacramento, California, United States, 95817
        • Recruiting
        • University of California, Davis Comprehensive Cancer Center
        • Contact:
        • Contact:
        • Principal Investigator:
          • Julie Dang, Ph.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Underserved and Diverse UCDCCC 19-County Catchment Area Population

Description

Inclusion Criteria:

  • UCDCCC (University of California, Davis Comprehensive Cancer Center) Catchment Area Population

Exclusion Criteria:

  • Above age 80

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
University of California, Davis Comprehensive Cancer Center's Catchment Area Population
Behavioral Intervention: Education and Training on Cancer Prevention and Education
Behavioral: Education
To educate catchment area residents on modifiable risk factors for cancer (e.g., screening, behavior, vaccination) and the importance of participation in cancer research. Provide participants with educational materials on cancer prevention, screening, and vaccination.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EDUCATE Pre-Presentation Participant Survey
Time Frame: 2 years
Assessment of participant's experience with cancer screening (Breast, Colorectal, Cervical, Lung or Prostate)
2 years
EDUCATE Post-Presentation Participant Survey and Evaluation
Time Frame: 2 years
Assessment of participant's likelihood to get a cancer screening (Breast, Colorectal, Cervical, Lung or Prostate)
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of California, Davis

Investigators

  • Principal Investigator: Julie Dang, Ph.D., University of California, Davis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 7, 2023

Primary Completion (Estimated)

June 30, 2030

Study Completion (Estimated)

June 30, 2030

Study Registration Dates

First Submitted

February 16, 2023

First Submitted That Met QC Criteria

March 6, 2023

First Posted (Actual)

March 9, 2023

Study Record Updates

Last Update Posted (Actual)

September 4, 2026

Last Update Submitted That Met QC Criteria

September 2, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1992110-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe